IDH1 and central nervous system cancer: Furthermore, K–M curve analyses was performed to analyze the different subtypes of clinical features, including gender (male and female), age (≤45 and >45 years), WHO grade (grade II–III and grade IV), and IDH mutation (mutation and wild), for assessing their potential to forecast the risk score for the survival time of glioma patients.